SCHEMBL1990967

SCHEMBL1990967

[2H]C([2H])([2H])c1ccc(OCc2ccccc2)c([C@H](CC(=O)Cl)c2ccccc2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACP1 P24666 1/20 0.42
PTPN12 Q05209 1/20 0.42
PTPN13 Q12923 1/20 0.42
SSU72 Q9NP77 1/20 0.42
GLRA1 P23415 1/20 0.41
KMT2A Q03164 2/20 0.40
GAA P10253 1/20 0.40
SLC6A9 P48067 1/20 0.39
SLC6A5 Q9Y345 1/20 0.39
PTGER1 P34995 3/20 0.39
PTGER4 P35408 1/20 0.39
PTGER3 P43115 1/20 0.39
PTGER2 P43116 1/20 0.39
MRGPRX4 Q96LA9 2/20 0.39
FFAR4 Q5NUL3 1/20 0.39
LRRK2 Q5S007 1/20 0.39
KDM4E B2RXH2 1/20 0.38
LMNA P02545 1/20 0.38
ALDH1A1 P00352 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4307252 0.93 ACP1 (0.42) ACP1PTPN12PTPN13SSU72GLRA1
SCHEMBL1989522 0.92 PTGER1 (0.46) ACP1PTPN12PTPN13SSU72GLRA1
SCHEMBL1989523 0.92 PTGER1 (0.46) ACP1PTPN12PTPN13SSU72GLRA1
SCHEMBL1995519 0.92 KMT2A (0.45) ACP1PTPN12PTPN13SSU72KMT2A
SCHEMBL1991544 0.85 KMT2A (0.40) ACP1PTPN12PTPN13SSU72KMT2A
SCHEMBL1990348 0.84 PTGER1 (0.51) KMT2AGAAPTGER1PTGER4PTGER3
SCHEMBL1990350 0.84 PTGER1 (0.51) KMT2AGAAPTGER1PTGER4PTGER3
SCHEMBL1994388 0.83 KMT2A (0.39) ACP1PTPN12PTPN13SSU72KMT2A
SCHEMBL1992692 0.82 FOLH1 (0.42) ACP1PTPN12PTPN13SSU72GLRA1
SCHEMBL2167258 0.82 LRRK2 (0.46) PTGER1LRRK2LMNAALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110152227-A1 DEUTERIUM LABELLED DERIVATIVES OF 3-(2-HYDROXY-5-METHYPHENYL)-N,N-DIISOPROPYL-3-PHENYLPROPYLAMINE AND METHODS OF USE THEREOF CONCERT PHARMACEUTICALS INC. (US) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152227-A1 DEUTERIUM LABELLED DERIVATIVES OF 3-(2-HYDROXY-5-METHYPHENYL)-N,N-DIISOPROPYL-3-PHENYLPROPYLAMINE AND METHODS OF USE THEREOF ADRB3, CHRM3, QDPR ACP1 4342/4885PTPN12 3011/4885PTPN13 2732/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.